Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524414 | NSE Symbol : | ISIN : INE744C01029 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
23-May-2025	28-May-2025	Accounts	Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve As per attachment. As per attachment. (As Per BSE Announcement Dated on :28.05.2025)
10-Feb-2025	13-Feb-2025	Quarterly Results	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve 1. To consider and approve Un-audited Financial Results for the quarter ended 31st December 2024 along with Limited Review Report and Statement of Asset and Liability thereof. 2. To consider and approve requests regarding from Mr. Nimish Bhishma Thakore Promoter / Promoter Group for reclassification from Promoter / Promoter Group into Public Category to Public Category in accordance with the Regulation 31A of SEBI (LODR) Regulation 2015. 3. Any other business with the permission of Chair. As per attachment. (As Per BSE Announcement dated on 13.02.2025)
11-Nov-2024	14-Nov-2024	Quarterly Results	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve As per attachment. As per attachment. (As per BSE Announcement dated on 14/11/2024)
25-Sep-2024	25-Sep-2024	Change in Directors	As per attachment.
09-Aug-2024	14-Aug-2024	Quarterly Results	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve As per attachment. As per attachment. (As Per Bse Announcement Dated on 14.08.2024)
22-May-2024	29-May-2024	Quarterly Results	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve 1. To approve the Standalone Audited Financial Results as per IND-AS along with Audited Report for the quarter and year ended on 31st March 2024. 2. To approve the Statement of Assets and Liabilities for the year ended March 31 2024. 3. Any other business with the permission of chair. 1. Approval of Audited Standalone Financial Results for the quarter and year ended March 31, 2024 as per Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. 2. Approval of statement of Assets and liabilities for the year ended March 31, 2024. 3. Also note that M/s.Bahedia & Associates, Statutory auditors of the Company have issued the Audit report for the financial year ended on March 31, 2024 with unmodified opinion pursuant to regulation 33(3)(d) of the SEBI(LODR), Regulations, 2015. Read less.. (As Per BSE Announcement Dated on 29.05.2024)
29-Apr-2024	29-Apr-2024	Change in Directors	As per attachment
29-Mar-2024	29-Mar-2024	Change in Directors	Outcome of Board Meeting held on 29-04-2024
22-Mar-2024	22-Mar-2024	Others	Outcome of Independent Directors Meeting
08-Feb-2024	14-Feb-2024	Quarterly Results	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To consider and take on record the Un-audited Financial Results of the Company for quarter and nine months ended 31st December 2023. 2. Any other business with the permission of the Chair. Outcome of the Board Meeting held today and Financial Results for Dec 31, 2023 (As Per BSE Announcement Dated on: 14/02/2024)
22-Dec-2023	29-Dec-2023	Change in Directors	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/12/2023 inter alia to consider and approve Intimation of Board Meeting to be held on 29-12-2023 at 11.30 AM Outcome of Board Meeting held on 29-12-2023 (As Per BSE Announcement Dated on 29/12/2023)
15-Nov-2023	18-Nov-2023	AGM	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/11/2023 inter alia to consider and approve Intimation of Board Meeting to be held on 18-11-2023 Outcome of Board Meeting held on 18-11-2023 (As Per BSE Announcement Dated on 18/11/2023)
03-Nov-2023	10-Nov-2023	Quarterly Results	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve 1. To consider and take on record the Un-audited Financial Results of the Company for quarter and six months ended 30th September 2023. 2. Any other business with the permission of the Chair. Results-Financial Results for Sep 30, 2023 (As Per BSE Announcement Dated on 10/11/2023)
03-Aug-2023	10-Aug-2023	Quarterly Results	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve 1. To consider and take on record the Un-Audited Financial Results of the Company for quarter ended 30th June 2023. 2. Any other business with the permission of the Chair. Results - Financial Results for June 30, 2023 (As Per BSE Announcement dated on 10.08.2023)
18-May-2023	25-May-2023	Accounts	NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2023 inter alia to consider and approve 1. To consider and take on record the Audited Financial Results of the Company for quarter and year ended 31st March 2023. 2. Any other business with the permission of the Chair. Outcome of Board Meeting held today and Financial Results for Mar 31, 2023 (As per BSE Announcement Dated on 25/05/2023)

1 2

LOGIN HERE

Norris Medicines Ltd

Board Meeting